Orion Market Research Report Central Nervous System (CNS) Biomarkers Market | Page 2

market. The global rise in adoption of the CNS market in developed and emerging economies has also boosted
the market growth considerably. CNS biomarkers as personalized medicine, disease risk assessment, diagnostic
development, drug discovery, and development are widely adopted across the globe. Personalized medicines
and drug discovery & development have significant contribution to the growth of the CNS market.
Browse the full report of CNS Biomarker Market, by Application (Drug Discovery & Development,
Personalized Medicine, Disease Risk Assessment, Other), by Type (Safety Biomarker, Efficacy Biomarker,
Pharmacodynamic Biomarker, Predictive Biomarker, Prognostic Biomarker, Validation Biomarker), by End
User (Diagnostic Centers, Hospital, Other) – Global Trends, Market Size, Share, Growth, Research and Forecast
2018-2023 at https://www.omrglobal.com/industry-reports/central-nervous-system-cns-biomarkers-
market/
Furthermore, the CNS Biomarkers Market is segmented on the basis of application, type, and end-user. The
report provides detailed & insightful chapters which include market overview, key findings, strategic
recommendations, market estimations, market determinants, key company analysis, market insights, company
profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. CNS Biomarkers Market by application
• Drug discovery & development
• Personalized medicine
• Disease risk assessment
• Other
2. CNS Biomarker Market by Type
• Safety biomarker
• Efficacy biomarker
• Pharmacodynamic biomarker
• Predictive biomarker
• Prognostic biomarker
• Validation biomarker
3. CNS Biomarker Market by End-User
• Diagnostic centers
• Hospital
• Other